Daxor Corporation

7.77
0.25 (3.32%)
At close: Apr 24, 2025, 1:47 PM
7.83
0.77%
After-hours: Apr 24, 2025, 01:47 PM EDT
3.32%
Bid 7
Market Cap 37.58M
Revenue (ttm) 154.2K
Net Income (ttm) 1.69M
EPS (ttm) -0.09
PE Ratio (ttm) -86.33
Forward PE 52
Analyst Strong Buy
Ask 8.15
Volume 200
Avg. Volume (20D) 7,116
Open 7.77
Previous Close 7.52
Day's Range 7.77 - 7.77
52-Week Range 6.55 - 10.00
Beta -0.06

About DXR

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation...

Sector Healthcare
IPO Date Jul 25, 1983
Employees 37
Stock Exchange NASDAQ
Ticker Symbol DXR
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for DXR stock is "Strong Buy." The 12-month stock price forecast is $25, which is an increase of 221.75% from the latest price.

Stock Forecasts